| Carceral sites (n = 6) |
---|---|
Organization characteristics, n (%) | |
 Corrections system structure | |
  Unified corrections system | 2 (33.3%) |
  State prison | 2 (33.3%) |
  Local jail | 2 (33.3%) |
 Single facility versus organization/system | |
  Single facility | 2 (33.3%) |
  Organization/system | 4 (66.7%) |
  Number of facilities, median (range) | 9 (4–13) facilities |
 Health care delivery model | |
  Contracted model | 4 (66.7%) |
  Hybrid model | 1 (16.7%) |
  Direct services model | 0 (0%) |
  Othera | 1 (16.7%) |
Opioid use disorder (MOUD) treatment characteristics, n (%) | |
 Organization/facility prescribes MOUD | 6 (100%) |
 MOUD prescribed for: | |
  Opioid withdrawal management | 6 (100%) |
  Maintenance for any persons with OUD | 6 (100%) |
  Induction and maintenance only immediately prior to release | 6 (100%) |
  Maintenance only for pregnant women | 3 (50.0%) |
  Maintenance only for persons entering on MOUD | 4 (66.7%) |
 Medications available within organization/facility | |
  Methadone | 5 (83.3%) |
  Sublingual buprenorphine | 6 (100%) |
  Extended-release buprenorphine | 3 (50.0%) |
  Sublingual buprenorphine/naloxone | 4 (66.7%) |
  Extended-release naltrexone | 6 (100%) |
 Available non-medication treatment for SUDs | |
  Peer mentor/navigator/recovery coach | 5 (83.3%) |
  Outpatient substance use treatment | 4 (66.7%) |
  Mutual- or self-help group meetings | 4 (66.7%) |
  Transfer to residential or inpatient substance use treatment in the community | 4 (66.7%) |
  Intensive outpatient substance use treatment | 3 (50.0%) |
  Co-occurring substance use and mental health services | 3 (50.0%) |
  Onsite short- or long-term residential treatment | 3 (50.0%) |
  Other recovery-based unit | 3 (50.0%) |
  Therapeutic community | 2 (33.3%) |
Telemedicine use, n (%) | |
 Prior to COVID-19, use of telemedicine for: | |
  Treatment of any health condition | 5 (83.3%) |
  Inducting incarcerated/detained persons on MOUD | 1 (20.0%) |
 Use of technology/methods used by persons who are incarcerated/detained to participate in substance use treatment or recovery support | |
  Video calls | 5 (83.3%) |
  Tablets | 4 (66.7%) |
  Computers | 3 (50.0%) |
  Kiosks | 1 (16.7%) |
  Portable kiosks | 1 (16.7%) |
  Cell phones | 1 (16.7%) |
  Other applications or software programs | 1 (16.7%) |
  Internet | 0 (0%) |
  Text messaging | 0 (0%) |
  Email | 0 (0%) |
Re-entry support and post-release referral practices, n (%) | |
 In the month prior to release, staff in the facility/organization engage in: | |
  Scheduling appointments with MOUD providers in the community | 6 (100%) |
  Providing assistance completing intake paperwork for MOUD providers in the community | 6 (100%) |
  Facilitating exchange of key information with MOUD providers in the community | 6 (100%) |
  Providing incarcerated/detained persons with the name(s) of MOUD providers in the community | 6 (100%) |
  Assisting with reactivation and/or applying for Medicaid, Veterans benefits, or other types of insurance for payment of MOUD | 6 (100%) |
  Inducting incarcerated/detained persons on MOUD | 5 (83.3%) |
  Coordinating MOUD services with probation/parole | 5 (83.3%) |
  Connecting incarcerated/detained persons to a peer mentor/navigator/recovery coach | 5 (83.3%) |
  Providing a bridge supply of MOUD | 5 (83.3%) |
  Providing a written prescription for MOUD | 4 (66.7%) |
  Providing or arranging transportation to a MOUD provider in the community | 2 (33.3%) |
 Facility/organization provides naloxone kits at release | 6 (100%) |
 Naloxone kits at release provided to: | |
  Everyone | 1 (16.7%) |
  Only individuals with opioid use problems/OUD | 4 (66.7%) |
  Individuals with any substance use disorder | 1 (16.7%) |